See every side of every news story
Published loading...Updated

Biostate AI and Weill Cornell Medicine Collaborate to Develop AI Models for Personalized Leukemia Care

  • Biostate AI and Weill Cornell Medicine formed a strategic collaboration on April 22, 2025.
  • This partnership aims to develop AI models for personalized patient prognosis, initially focusing on leukemia.
  • They will combine samples from Weill Cornell's leukemia program with Biostate AI's RNA sequencing technology.
  • A pilot phase will use 1,000 retrospective samples to prototype an AML-specific AI model.
  • This project seeks to improve treatment selection and outcomes for leukemia patients.
Insights by Ground AI
Does this summary seem wrong?

14 Articles

All
Left
1
Center
7
Right
Hastings TribuneHastings Tribune
+13 Reposted by 13 other sources
Center

Biostate AI and Weill Cornell Medicine Collaborate to Develop AI Models for Personalized Leukemia Care

HOUSTON & NEW YORK--(BUSINESS WIRE)--Apr 22, 2025-

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 88% of the sources are Center
88% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Mid Florida Newspapers broke the news in on Tuesday, April 22, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.